$65.72
1.69% yesterday
Nasdaq, Jul 11, 10:00 pm CET
ISIN
US4364401012
Symbol
HOLX

Hologic Target price 2025 - Analyst rating & recommendation

Hologic Classifications & Recommendation:

Buy
39%
Hold
57%
Sell
4%

Hologic Price Target

Target Price $66.30
Price $65.72
Potential
Number of Estimates 19
19 Analysts have issued a price target Hologic 2026 . The average Hologic target price is $66.30. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 28 analysts: 11 Analysts recommend Hologic to buy, 16 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Hologic stock has an average upside potential 2026 of . Most analysts recommend the Hologic stock at Hold.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Sep '24 2025
Estimates
Revenue Billion $ 4.03 4.15
0.00% 2.99%
EBITDA Margin 24.80% 32.69%
3.13% 31.83%
Net Margin 19.59% 22.90%
73.14% 16.90%

24 Analysts have issued a sales forecast Hologic 2025 . The average Hologic sales estimate is

$4.2b
Unlock
. This is
3.09% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$4.3b 6.89%
Unlock
, the lowest is
$4.0b 1.43%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $4.0b 0.00%
2025
$4.2b 2.99%
Unlock
2026
$4.4b 4.91%
Unlock
2027
$4.6b 5.21%
Unlock
2028
$4.9b 6.61%
Unlock
2029
$5.2b 5.83%
Unlock

21 Analysts have issued an Hologic EBITDA forecast 2025. The average Hologic EBITDA estimate is

$1.4b
Unlock
. This is
35.38% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$1.4b 42.46%
Unlock
, the lowest is
$1.3b 28.69%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $999m 3.13%
2025
$1.4b 35.78%
Unlock
2026
$1.4b 5.23%
Unlock
2027
$1.5b 5.67%
Unlock
2028
$1.6b 5.77%
Unlock
2029
$1.7b 4.64%
Unlock

EBITDA Margin

2024 24.80% 3.13%
2025
32.69% 31.83%
Unlock
2026
32.79% 0.31%
Unlock
2027
32.93% 0.43%
Unlock
2028
32.67% 0.79%
Unlock
2029
32.30% 1.13%
Unlock

25 Hologic Analysts have issued a net profit forecast 2025. The average Hologic net profit estimate is

$951m
Unlock
. This is
70.74% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$987m 77.37%
Unlock
, the lowest is
$906m 62.80%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $790m 73.14%
2025
$951m 20.39%
Unlock
2026
$1.0b 7.93%
Unlock
2027
$1.1b 10.50%
Unlock
2028
$1.2b 5.10%
Unlock
2029
$1.2b 0.73%
Unlock

Net Margin

2024 19.59% 73.14%
2025
22.90% 16.90%
Unlock
2026
23.56% 2.88%
Unlock
2027
24.74% 5.01%
Unlock
2028
24.39% 1.41%
Unlock
2029
23.21% 4.84%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Sep '24 2025
Estimates
Earnings Per Share $ 3.32 4.27
81.42% 28.61%
P/E 15.41
EV/Sales 3.75

25 Analysts have issued a Hologic forecast for earnings per share. The average Hologic EPS is

$4.27
Unlock
. This is
73.58% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$4.43 80.08%
Unlock
, the lowest is
$4.07 65.45%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $3.32 81.42%
2025
$4.27 28.61%
Unlock
2026
$4.60 7.73%
Unlock
2027
$5.09 10.65%
Unlock
2028
$5.35 5.11%
Unlock
2029
$5.39 0.75%
Unlock

P/E ratio

Current 26.72 6.72%
2025
15.41 42.32%
Unlock
2026
14.28 7.33%
Unlock
2027
12.92 9.52%
Unlock
2028
12.29 4.88%
Unlock
2029
12.20 0.73%
Unlock

Based on analysts' sales estimates for 2025, the Hologic stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.86 11.67%
2025
3.75 2.92%
Unlock
2026
3.57 4.69%
Unlock
2027
3.39 4.95%
Unlock
2028
3.18 6.20%
Unlock
2029
3.01 5.51%
Unlock

P/S ratio

Current 3.64 16.13%
2025
3.53 3.00%
Unlock
2026
3.36 4.69%
Unlock
2027
3.20 4.95%
Unlock
2028
3.00 6.20%
Unlock
2029
2.83 5.51%
Unlock

Current Hologic Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Citigroup
Locked
Locked
Locked Jul 09 2025
Evercore ISI Group
Locked
Locked
Locked Jul 08 2025
Needham
Locked
Locked
Locked May 28 2025
Stephens & Co.
Locked
Locked
Locked May 13 2025
Morgan Stanley
Locked
Locked
Locked May 05 2025
Needham
Locked
Locked
Locked May 02 2025
Evercore ISI Group
Locked
Locked
Locked May 02 2025
Analyst Rating Date
Locked
Citigroup:
Locked
Locked
Jul 09 2025
Locked
Evercore ISI Group:
Locked
Locked
Jul 08 2025
Locked
Needham:
Locked
Locked
May 28 2025
Locked
Stephens & Co.:
Locked
Locked
May 13 2025
Locked
Morgan Stanley:
Locked
Locked
May 05 2025
Locked
Needham:
Locked
Locked
May 02 2025
Locked
Evercore ISI Group:
Locked
Locked
May 02 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today